M Vourc'h-Jourdain

Summary

Country: France

Publications

  1. doi request reprint Large congenital melanocytic nevi: Therapeutic management and melanoma risk: A systematic review
    Morgane Vourc'h-Jourdain
    Dermatology Department, Centre Hospitalier Universitaire de Nantes, Nantes, France on behalf of the Association Recommandations En Dermatologie aRED, Société Française de Dermatologie Electronic address
    J Am Acad Dermatol 68:493-498.e14. 2013
  2. doi request reprint Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study
    M Vourc'h-Jourdain
    Clinique Dermatologique, CHU Hotel Dieu, Nantes, France
    Dermatology 218:246-51. 2009
  3. doi request reprint Melanoma gene expression and clinical course
    M Vourc'h-Jourdain
    Unit of Skin Cancer Nantes University Hospital, Nantes, France
    Arch Dermatol Res 301:673-9. 2009

Detail Information

Publications3

  1. doi request reprint Large congenital melanocytic nevi: Therapeutic management and melanoma risk: A systematic review
    Morgane Vourc'h-Jourdain
    Dermatology Department, Centre Hospitalier Universitaire de Nantes, Nantes, France on behalf of the Association Recommandations En Dermatologie aRED, Société Française de Dermatologie Electronic address
    J Am Acad Dermatol 68:493-498.e14. 2013
    ..They occur in 1 in 20,000 to 1 in 500,000 newborns. Therapeutic management of LCMN remains controversial and is often decided according to melanoma risk...
  2. doi request reprint Patient-oriented SCORAD: a self-assessment score in atopic dermatitis. A preliminary feasibility study
    M Vourc'h-Jourdain
    Clinique Dermatologique, CHU Hotel Dieu, Nantes, France
    Dermatology 218:246-51. 2009
    ..Patient involvement in the treatment process is of major current interest. There are very few validated patient self-assessment tools for atopic dermatitis (AD)...
  3. doi request reprint Melanoma gene expression and clinical course
    M Vourc'h-Jourdain
    Unit of Skin Cancer Nantes University Hospital, Nantes, France
    Arch Dermatol Res 301:673-9. 2009
    ..However, with regard to certain sub-groups, such as stage III samples, tumour gene expression was significantly associated with survival...